Lucid Diagnostics Files 8-K on Officer/Director Changes
Ticker: LUCD · Form: 8-K · Filed: Sep 25, 2025 · CIK: 1799011
Sentiment: neutral
Topics: management-change, corporate-governance, filing
TL;DR
Lucid Diagnostics 8-K: Leadership changes and compensation details filed.
AI Summary
Lucid Diagnostics Inc. filed an 8-K on September 25, 2025, reporting events as of September 22, 2025. The filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. It also includes Regulation FD disclosures and financial statements/exhibits.
Why It Matters
This filing indicates potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational oversight.
Risk Assessment
Risk Level: medium — Changes in directors or officers can signal internal shifts that may affect company strategy or stability.
Key Players & Entities
- Lucid Diagnostics Inc. (company) — Registrant
- September 22, 2025 (date) — Date of earliest event reported
- September 25, 2025 (date) — Filing date
FAQ
What specific officer or director positions were affected by the changes reported in this 8-K?
The filing indicates changes related to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers,' but does not specify the exact individuals or roles in the provided text.
Are there any details regarding new compensatory arrangements for officers mentioned?
The filing lists 'Compensatory Arrangements of Certain Officers' as an item covered, but the specific details of these arrangements are not included in the provided text.
What is the significance of the 'Regulation FD Disclosure' item in this filing?
Regulation FD (Fair Disclosure) ensures that material information is broadly disseminated to the public, suggesting that the company may be making public disclosures that were previously non-public.
When was Lucid Diagnostics Inc. incorporated, and what is its fiscal year end?
Lucid Diagnostics Inc. was incorporated in Delaware and its fiscal year ends on December 31.
What is the principal executive office address for Lucid Diagnostics Inc.?
The principal executive offices are located at 360 Madison Avenue, 25th Floor, New York, NY 10017.
Filing Stats: 657 words · 3 min read · ~2 pages · Grade level 10.4 · Accepted 2025-09-25 08:57:08
Key Financial Figures
- $0.001 — ch registered Common Stock, Par Value $0.001 Per Share LUCD The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex99-1.htm (EX-99.1) — 16KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001493152-25-014872.txt ( ) — 234KB
- lucd-20250922.xsd (EX-101.SCH) — 3KB
- lucd-20250922_lab.xml (EX-101.LAB) — 33KB
- lucd-20250922_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On September 25, 2025, the Company issued a press release announcing the appointment of Mr. Palumbo. The press release is attached as Exhibit 99.1 hereto. The information furnished under Item 7.01, including the exhibit related thereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any disclosure document of the Company, except as shall be expressly set forth by specific reference in such document.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 99.1 Press release. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: September 25, 2025 LUCID DIAGNOSTICS INC. By: /s/ Dennis McGrath Dennis McGrath Chief Financial Officer 3